Shares of Catheter Precision, Inc. (NYSEAMERICAN:VTAK – Get Free Report) were up 2.5% on Tuesday . The stock traded as high as $0.44 and last traded at $0.44. Approximately 94,084 shares were traded during mid-day trading, a decline of 91% from the average daily volume of 1,044,929 shares. The stock had previously closed at $0.43.
Catheter Precision Price Performance
The company has a debt-to-equity ratio of 0.12, a current ratio of 0.66 and a quick ratio of 0.65.
Catheter Precision Company Profile
Catheter Precision, Inc designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.
Recommended Stories
- Five stocks we like better than Catheter Precision
- Insider Buying Explained: What Investors Need to Know
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- What Investors Need to Know About Upcoming IPOs
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for Catheter Precision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catheter Precision and related companies with MarketBeat.com's FREE daily email newsletter.
